Surrogacy Market Overview
The Surrogacy Market is expanding as fertility challenges, delayed parenthood, advances in assisted reproductive technologies, and growing awareness of alternative family-building options increase demand for surrogacy services. Improvements in reproductive medicine, embryo screening, fertility preservation, and coordinated care are supporting the development of increasingly sophisticated surrogacy programs.
According to the Market Research Future report updated August 24, 2026, the global Surrogacy Market was valued at USD 118.9 billion in 2025 and is projected to grow from USD 130.6 billion in 2026 to USD 287.4 billion by 2035, registering a CAGR of 9.8% during the forecast period 2026–2035. North America holds the largest regional share at approximately 42% of the global market, while Asia-Pacific is projected to be the fastest-growing region at a CAGR of around 11.5%. Gestational surrogacy represents the dominant surrogacy type, while Traditional Surrogacy is projected to register comparatively strong growth. Infertility is the leading application category, while Same-Sex Couples represent an increasingly important growth segment. Fertility clinics account for the largest share among service providers.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Surrogacy Market include:
Circle Surrogacy
Growing Generations
ConceiveAbilities
Creative Family Connections
New Hope Fertility Center
The Surrogacy Center
Surrogacy America
Extraordinary Conceptions
Family Source Consultants
Global Surrogacy Solutions
The Surrogacy Market is being shaped by advances in assisted reproductive technology and the growing sophistication of fertility-care ecosystems. In-vitro fertilization, preimplantation genetic testing, embryo cryopreservation, and improved reproductive screening are helping intended parents and fertility specialists optimize treatment pathways. Digital platforms are also simplifying communication, documentation, scheduling, and coordination between intended parents, gestational carriers, fertility clinics, and legal professionals. At the same time, evolving regulations and ethical frameworks remain critical factors influencing cross-border surrogacy services and market accessibility.
The Surrogacy Market can be segmented by Type, Technology, Service Provider, Age Group, and Region. By type, the market includes Gestational Surrogacy and Traditional Surrogacy, with Gestational Surrogacy accounting for the dominant share because the surrogate has no genetic relationship to the child. By technology, services are supported by IVF, embryo transfer, genetic testing, cryopreservation, and related assisted reproductive technologies. By application, infertility remains the major demand driver, while single parents and same-sex couples represent important emerging user groups. By service provider, Fertility Clinics account for the largest share, followed by specialized surrogacy agencies and other reproductive-health providers. Regional markets include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Significant opportunities are emerging through integrated fertility and surrogacy services, international patient coordination, digital case-management platforms, genetic screening, embryo banking, and improved support services for intended parents and gestational carriers. Asia-Pacific offers considerable growth potential as fertility treatment infrastructure expands, while established markets are increasingly emphasizing comprehensive medical, psychological, legal, and administrative support throughout the surrogacy journey.
Recent Developments and Market Trends:
The growing adoption of gestational surrogacy is strengthening demand for IVF, embryo-transfer procedures, genetic testing, and coordinated reproductive healthcare services.
Advances in preimplantation genetic testing and embryo screening are improving the ability of fertility specialists to evaluate embryos before transfer.
Digital surrogacy platforms are increasingly being used to coordinate intended parents, gestational carriers, fertility clinics, legal professionals, documentation, and treatment schedules.
The expansion of fertility preservation and delayed parenthood is contributing to broader demand for assisted reproductive technologies and alternative family-building pathways.
Regulatory and ethical frameworks surrounding surrogacy continue to evolve, increasing the importance of compliant cross-border coordination, informed consent, and comprehensive participant support.
Reasons to Buy the Report:
Understand the projected growth trajectory of the Surrogacy Market through 2035, including its 9.8% CAGR and forecast valuation of USD 287.4 billion.
Assess the competitive landscape and strategic positioning of major fertility clinics, surrogacy agencies, and reproductive healthcare service providers.
Identify the largest and fastest-growing surrogacy type, technology, application, service-provider, and regional segments shaping future opportunities.
Evaluate key market drivers, restraints, regulatory developments, demographic trends, and technological advances influencing surrogacy demand.
Gain strategic insights into gestational surrogacy, IVF, embryo screening, digital coordination platforms, fertility preservation, and emerging international markets.
Future Outlook:
The Surrogacy Market is expected to maintain strong growth through 2035 as infertility prevalence, delayed parenthood, assisted reproductive technology adoption, and changing family-building preferences continue to increase demand for surrogacy services. Gestational Surrogacy is expected to remain the dominant type because of its established clinical integration with IVF and the absence of a genetic relationship between the surrogate and child. IVF and associated embryo-transfer technologies will remain central to the market as fertility providers improve treatment protocols and embryo selection, while genetic testing and cryopreservation will continue to expand their role in reproductive planning. Infertility will remain the largest application driver, while demand from same-sex couples, single parents, and other intended-parent groups is expected to contribute to market diversification. Fertility Clinics will continue to account for a substantial share of service delivery, supported by integrated reproductive healthcare capabilities. North America is expected to retain regional leadership because of its advanced fertility infrastructure and established service ecosystem, while Asia-Pacific is projected to remain the fastest-growing region at approximately an 11.5% CAGR as fertility-care infrastructure and assisted reproductive services expand. Overall, advances in IVF, embryo screening, digital case management, fertility preservation, and integrated reproductive services are expected to support the Surrogacy Market’s expansion to USD 287.4 billion by 2035.
➤➤Explore Our Latest Related Reports:
